This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bionomics Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Thomas Stumpfig: Innovator in Therapeutic Formulations
Introduction
Thomas Stumpfig is a notable inventor based in Bend, OR (US). He has made significant contributions to the field of therapeutic formulations, particularly in the treatment of central nervous system diseases. His work focuses on innovative solutions that aim to improve patient outcomes.
Latest Patents
Stumpfig holds a patent for "Therapeutic formulations and uses thereof." This invention relates to formulations of compound (I) (BNC210), an allosteric modulator of the α7-nicotinic receptor with non-sedative anxiolytic effects. Specifically, it covers solid dispersions, methods of manufacture, and therapeutic methods and uses in treating diseases of the central nervous system. He has 1 patent to his name.
Career Highlights
Throughout his career, Stumpfig has been associated with Bionomics Inc., where he has played a crucial role in advancing therapeutic innovations. His expertise in the field has positioned him as a key figure in the development of new treatment modalities.
Collaborations
Stumpfig has collaborated with notable colleagues, including Dharam Paul and Julia Crossman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Thomas Stumpfig is a dedicated inventor whose work in therapeutic formulations has the potential to make a significant impact on the treatment of central nervous system diseases. His contributions to the field exemplify the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile